维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Barrow BA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy显示文摘	Rachman J Levy JC Barrow BA		0，，：	1
2	Hyperglycaemic sibling so Type II (non insulin dependent) diabetic patients have increased PAI-1 ,central obesity and insulin resistance compared with their paired nor Moglycaemic sibling显示文摘	Herlihy OM Barrow BA Grant PJ	2002	Diabetologia2002，45，5：	1
3	Hyperglycaemic siblings of type Ⅱ (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling 显示文摘	Herlihy OM Barrow BA Grant PJ	2002	Diahetologia2002，45，5：	1
4	Hyperglycemic siblings of Type II (non -insulin -dependent) diabetic patients have increased PAI- 1, central obesity and insulin resistance compared with their paired nonno-glycemic sibling 显示文摘	Herlihy OM Barrow BA Grant PJ	2002	Diabetologia2002，45，：	1
5	Near-normalisation of diurnal glucose oncentra -tions by continuous administration of glucagon-like peptide-1(GLP-1) in subjects with NIDDM显示文摘	Rachman J Barrow BA Levy JC	1997	Diabetologia1997，40，：	1
6	Relative hyperpminsulinenutia of NIDDM persists despite the reduction of hyperglycemia with insuhm or sulfonylurea therapy显示文摘	Racb man J Levy JC Barrow BA	1997	Diabets1997，46，10：	1
7	Airway hyperresponsiveness in allergic rhinitis a risk factor for asthma显示文摘	Braman SS Barrows AA Decotiis BA	1987	Chest1987，91，5：	1
8	Increased PAl-1 in hyperglycaemic compared with normoglycaemic siblings显示文摘	Herlihy OM Barrow BA Grant PJ	2002	Diabetologia2002，45，5：	1
9	Relative hyperproin -sulinemia of NIDDM persistes the reduction of hyperglycemia with insulin or sulfonyurea therapy显示文摘	Rachman J Levey JC Barrow BA	1997	Diabetes1997，46，：	1
10	Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy显示文摘	Rachman J Levy JC Barrow BA	1997	Diabetes1997，46，10：	1
11	Relative hyperproinsulinemia of NIDDM persistes the reduction of hyperglycemia with insulin or sulfonylurea therapy显示文摘	Chman J Levey JC Barrow BA	1997	Diabetes1997，46，：	1
12	Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy显示文摘	Rachman J Levy JC Barrow BA	1997	Diabetes1997，46，10：	1
13	The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity 显示文摘	Sabatini DM Pierchala BA Barrow RK	1995	J Biol Chem1995，270，20：	1
14	Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy显示文摘	Rachman J Levy JC Barrow BA	1997	Diabetes1997，46，10：	1
15	Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling 显示文摘	Herlihy OM Barrow BA Grant PJ	2002	Diabetologia2002，45，5：	1
16	The Rapamycin and FKBP12 target (RAFT) display sphospatidylinositol 4 - kinaseactivity显示文摘	Sabatini DM Pierchala BA Barrow RK	1995	J Biol Chem1995，270，20：	1
17	Relative hyperproinsulinemia of NIDDM persistes the reduction of hyperglycemia with insulin or sulfonyurea therapy显示文摘	Levey JC Barrow BA	1997	Diabetes1997，46，：	1
18	Hyperglycaemic siblings of Type II ( non-insulin- dependent) diabetic patients have increased PAI 1, central obesity and insulin resistance compared with their paired normoglyeaemic sibling 显示文摘	Herlihy OM Barrow BA Grant PJ	2002	Diabetologia2002，45，5：	1
19	Relative hyperproinsulin of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy显示文摘	Rachman J Levy JC Barrow BA	1997	Diabetes1997，46，12：	1
20	Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy显示文摘	Rachman J Levy JC Barrow BA	2000	Diabetes2000，46，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示